Cargando…

Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes

PURPOSE: To investigate the efficacy, safety, and anatomical outcomes associated with intravitreal anti-vascular endothelial growth factor (VEGF) treatment of retinopathy of prematurity (ROP). METHODS: We performed a retrospective review of intravitreal anti-VEGF (bevacizumab or ranibizumab) treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Hyun Goo, Choi, Eun Young, Byeon, Suk Ho, Kim, Sung Soo, Koh, Hyoung Jun, Lee, Sung Chul, Kim, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Ophthalmological Society 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288015/ https://www.ncbi.nlm.nih.gov/pubmed/30549468 http://dx.doi.org/10.3341/kjo.2018.0011

Ejemplares similares

Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity
por: Kang, Hyun Goo, et al.
Publicado: (2019)

Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: A survey among the members of Indian Retinopathy of Prematurity Society
por: Gangwe, Anil, et al.
Publicado: (2021)

Clinical characteristics, risk factors, and surgical outcomes of secondary macular hole after vitrectomy
por: Kang, Hyun Goo, et al.
Publicado: (2019)

Anti-vascular endothelial growth factor therapy in retinopathy of prematurity: An updated literature review
por: Alzuabi, Asma K., et al.
Publicado: (2022)

Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
por: Choi, Wungrak, et al.
Publicado: (2020)

Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

Safety and efficacy of intravitreal anti vascular endothelial growth factor for severe posterior retinopathy of prematurity with flat fibrovascular proliferation
por: Maitra, Puja, et al.
Publicado: (2023)

Long-term surgical outcomes of primary retropupillary iris claw intraocular lens implantation for the treatment of intraocular lens dislocation
por: Choi, Eun Young, et al.
Publicado: (2021)

Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats’ disease in Korea
por: Kang, Hyun Goo, et al.
Publicado: (2021)

Association Between Clinical Biomarkers and Optical Coherence Tomography Angiography Parameters in Type 2 Diabetes Mellitus
por: Choi, Eun Young, et al.
Publicado: (2020)

Comparison of Individual Retinal Layer Thicknesses between Highly Myopic Eyes and Normal Control Eyes Using Retinal Layer Segmentation Analysis
por: Kim, Jin Hyung, et al.
Publicado: (2019)

Commentary: Looking beyond anti-vascular endothelial growth factor – Novel therapeutic targets for retinopathy of prematurity
por: Dogra, Mohit, et al.
Publicado: (2021)

Commentary: Are we there yet? Role of anti-vascular endothelial growth factor and laser in the management of retinopathy of prematurity
por: Sindal, Manavi D, et al.
Publicado: (2021)

Primary and additional treatment preference in aggressive retinopathy of prematurity and type 1 retinopathy of prematurity
por: Jang, Ji Hye, et al.
Publicado: (2023)

Oxygen care and treatment of retinopathy of prematurity in ocular and neurological prognosis
por: Kang, Hyun Goo, et al.
Publicado: (2022)

Indocyanine Green Angiographic Features of Myopic Subfoveal Choroidal Neovascularization as a Prognostic Factor after Photodynamic Therapy
por: Byeon, Suk Ho, et al.
Publicado: (2006)

Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity
por: Kondo, Chiori, et al.
Publicado: (2022)

Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
por: Taher, Nada O., et al.
Publicado: (2022)

Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea
por: Choi, Eun Young, et al.
Publicado: (2016)

A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity
por: Pertl, Laura, et al.
Publicado: (2015)

Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity
por: Ramshekar, Aniket, et al.
Publicado: (2021)

Comparison of Individual Retinal Layer Thicknesses after Epiretinal Membrane Surgery with or without Internal Limiting Membrane Peeling
por: Lee, Chul Hee, et al.
Publicado: (2018)

Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity
por: Velez-Montoya, Raul, et al.
Publicado: (2010)

Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of Prematurity
por: Goswami, Binita, et al.
Publicado: (2015)

Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
por: Chung, Eun Jee, et al.
Publicado: (2011)

The effect of baicalin in a mouse model of retinopathy of prematurity
por: Jo, Hyoung, et al.
Publicado: (2015)

Prognostic Factors and Long-term Surgical Outcomes for Exudative Age-related Macular Degeneration with Breakthrough Vitreous Hemorrhage
por: Kim, Tae Young, et al.
Publicado: (2020)

Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF(165)b Isoform in the Vitreous of Patients with Retinopathy of Prematurity
por: Zhao, Min, et al.
Publicado: (2015)

Timing of laser following intravitreal anti-vascular endothelial growth factor injections for aggressive posterior zone 1 retinopathy of prematurity
por: Vinekar, Anand
Publicado: (2021)

Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries
por: Dogra, Mangat Ram, et al.
Publicado: (2023)

Capillary-free Vascularized Retina in Patients with Aggressive Posterior Retinopathy of Prematurity and Late Retinal Capillary Formation
por: Ahn, Seong Joon, et al.
Publicado: (2013)

Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization
por: Lee, Christopher Seungkyu, et al.
Publicado: (2015)

Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP)
por: Li, Zijing, et al.
Publicado: (2018)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
por: Dudani, Ajay Indur, et al.
Publicado: (2019)

Elevated aqueous endothelin-1 concentrations in advanced diabetic retinopathy
por: Kang, Hae Min, et al.
Publicado: (2022)

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
por: Chen, Xuting, et al.
Publicado: (2019)

Estimated Prevalence and Risk Factor for Age-related Maculopathy
por: Roh, Mi In, et al.
Publicado: (2008)

Clinical utility of aqueous humor polymerase chain reaction and serologic testing for suspected infectious uveitis: a single-center retrospective study in South Korea
por: Choi, Wungrak, et al.
Publicado: (2020)

Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review
por: Tan, Qing-Qing, et al.
Publicado: (2019)

Short-term effects of intravitreal anti-vascular endothelial growth factor agents on body weight and multiple systems after treatment for retinopathy of prematurity
por: Chen, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_spk6jqr4am55itf78hv8mhohvm